Showing results (21-30 of 418) with videos related to
Sort By:
Pageof 42
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 4, 2014
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiationFrancesco Sabbatino, Celeste Fusciello, Domenico Somma, et al.Seminars in Cancer Biology|January 8, 2004
HLA-G in melanoma: can the current controversies be solved?Chien-Chung Chang, Soldano FerroneClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2012
For breast cancer prognosis, immunoglobulin kappa chain surfaces to the topTheresa L Whiteside, Soldano FerroneCancer Immunology, Immunotherapy : CII|June 20, 2006
Immune selective pressure and HLA class I antigen defects in malignant lesionsChien-Chung Chang, Soldano FerroneSurgical Oncology Clinics of North America|November 21, 2007
Tumor microenvironment and immune escapeSoldano Ferrone, Theresa L WhitesideOncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano FerroneAdvances in Cancer Research|November 13, 2010
Functional and clinical relevance of chondroitin sulfate proteoglycan 4Michael Campoli, Soldano Ferrone, Xinhui WangImmunological Investigations|March 14, 2017
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of ImmunotherapyCristina Maccalli, Giorgio Parmiani, Soldano FerroneJournal of Immunological Methods|September 6, 2003
Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulumTakeshi Ogino, Xinhui Wang, Soldano FerroneTrends in Immunology|January 28, 2003
HLA-G and MIC expression in tumors and their role in anti-tumor immunityBarbara Seliger, Hinrich Abken, Soldano FerronePageof 42